Keyphrases
Legionnaires' Disease
100%
Legionella
79%
Legionella Pneumophila
76%
Pulsed-field Gel Electrophoresis
46%
Spain
38%
Catalonia
36%
Community-acquired Pneumonia
34%
Sequence-based Typing
32%
Hospital-acquired
24%
Cooling Tower
23%
Environmental Isolates
23%
Methicillin-resistant Staphylococcus Aureus
23%
Legionella Pneumonia
23%
Molecular Epidemiology
21%
Macrolides
20%
University Hospital
18%
Adult Patients
16%
Epidemiological Characteristics
16%
HIV Patients
15%
Staphylococcus Aureus Bacteremia
15%
Disseminated Tuberculosis
15%
Post-COVID-19 Era
15%
Case Series Analysis
15%
Western European Countries
15%
Delayed Diagnosis
15%
Cloxacillin
15%
Fosfomycin
15%
Clinical Features
14%
Legionella Infection
14%
Risk Factors
14%
Fluoroquinolones
13%
Cytopathogenicity
13%
COVID-19 Vaccine
12%
Virulence
12%
Chemotherapy
11%
Community-acquired
11%
Microbiology
11%
Sequence Type
11%
Humoral Response
11%
Legionella Species
11%
Primary Antibody Deficiency
11%
Legionellosis
10%
Subgrouping
10%
H1N1
10%
Schistosomiasis
10%
Treatment Strategy
10%
Schistosoma Infection
10%
Copyright
10%
Monoclonal Antibody
10%
Clinical Data
10%
Medicine and Dentistry
Legionella
87%
Pontiac Fever
62%
Legionella pneumophila
49%
Infection
40%
Pulsed Field Gel Electrophoresis
31%
Diseases
22%
Community-Acquired Pneumonia
20%
Human Immunodeficiency Virus
17%
COVID-19
17%
Diagnosis
17%
Urinary System
15%
Immigrant
15%
Schistosomiasis
15%
Miliary Tuberculosis
15%
Delayed Diagnosis
15%
Health Care
13%
Cohort Effect
12%
Intensive Care Unit
11%
Antibiotic Therapy
10%
Human Immunodeficiency Virus Infection
10%
Prevalence
9%
Hospital-Acquired Pneumonia
8%
Patient Characteristics
8%
Pneumococcus
8%
Early Diagnosis
8%
Legionella Infection
7%
Manometry
7%
Lymphadenitis
7%
Chagas Disease
7%
Tuberculous Lymphadenitis
7%
Population Structure
7%
Immunocompromised Patient
7%
Esophageal Motility Disorder
7%
Case-Control Study
7%
Opportunistic Infection
7%
Fungal Colonization
7%
Elderly Patient
7%
Prospective Study
7%
Sialidase Inhibitor
7%
Health Care Facility
7%
Genetic Variability
7%
Influenza A
7%
Clinical Study
7%
Infective Endocarditis
7%
Humoral Immunity
7%
Epinephrine
7%
Checklist
7%
COVID-19 Vaccination
7%
Humoral Immune Deficiency
7%
Molecular Epidemiology
7%
Pharmacology, Toxicology and Pharmaceutical Science
Legionella
90%
Legionnaire Disease
80%
Infection
65%
Legionella pneumophila
26%
Quinolone Derivative
21%
Macrolide
19%
Community Acquired Pneumonia
17%
Pulsed-Field Gel Electrophoresis
16%
Disease
16%
Staphylococcal Bacteremia
15%
Methicillin Susceptible Staphylococcus Aureus
15%
Fosfomycin
15%
Cloxacillin
15%
Human Immunodeficiency Virus Infection
10%
Neoplasm
10%
Prospective Study
9%
Chemotherapy
9%
Staphylococcus Aureus
8%
Hospital Acquired Pneumonia
8%
Sialidase Inhibitor
7%
Clinical Study
7%
Febrile Neutropenia
7%
Pneumococcal Infection
7%
Opportunistic Infection
7%
2009 H1N1 Influenza
7%
Meticillin
7%
Influenza A
7%
HIV
7%
Case-Control Study
7%
Schistosomiasis
7%
Phase IV
7%
Inflammation
7%
Streptococcus Agalactiae
7%
Streptococcus suis
7%
Erythromycin
6%
Molecular Epidemiology
6%
Immunosuppressive Agent
6%
Monoclonal Antibody
6%
Azithromycin
5%
Relenza
5%
Influenza A Virus (H1N1)
5%
Oseltamivir
5%
Mortality Rate
5%